Company identity 1 fact
Location
South San Francisco, CA
SEC filing record 1 fact
Fiscal year end
31 December
SUTRO BIOPHARMA, INC. has filed 608 SEC EDGAR filings since 08 Nov 2006

SEC filing history

Showing 301-325 of 603 matching filings.

Per page
25
Current page
13
4

FORM 4 SUBMISSION

Filing date
07 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-263113

S-8

Filing date
01 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-255014

POS AM

Filing date
01 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-255014

POSASR

Filing date
28 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90656

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90656

SC 13G/A filing

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Feb 2022
Reporting date
08 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90656

SC 13G filing

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90656

SC 13G/A filing

Filing date
03 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2022
Reporting date
29 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2022
Reporting date
29 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2022
Reporting date
29 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2022
Reporting date
29 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2022
Reporting date
29 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2022
Reporting date
29 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2022
Reporting date
29 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90656

THE SCHEDULE 13G

Filing date
18 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .